相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Innovative Pediatric Development for Secukinumab in Psoriasis: Faster Patient Access, Reduction of Patients on Control
Ruquan You et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results
Nina Magnolo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial
C. Bodemer et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Skin Disease in Children: Effects on Quality of Life, Stigmatization, Bullying, and Suicide Risk in Pediatric Acne, Atopic Dermatitis, and Psoriasis Patients
Katherine A. Kelly et al.
CHILDREN-BASEL (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Skin and soft tissue infections in biological therapy for psoriasis-A case report and systematic review of the literature
Shani Fisher et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)
Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis
Marina Nishida et al.
JOURNAL OF DERMATOLOGY (2020)
Efficacy and safety of ixekizumab in a phaseIII, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)
A. S. Paller et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study
S. Philipp et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period
M. Megna et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis?
Matteo Megna et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Paradoxical gastrointestinal effects of interleukin-17 blockers
Marine Fauny et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Staphylococcal toxic shock syndrome in a child with interleukin-17 inhibitor treatment for psoriasis
Maria Sanchez Martin et al.
PEDIATRIC DERMATOLOGY (2020)
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
Stefan Schreiber et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis
Leah Ellis Wells et al.
PEDIATRIC DERMATOLOGY (2019)
Pediatric psoriasis: Evolving perspectives
Lawrence F. Eichenfield et al.
PEDIATRIC DERMATOLOGY (2018)
Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work
Po-Han Ho et al.
JOURNAL OF DERMATOLOGY (2018)
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial
Kim Papp et al.
LANCET (2017)
Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis
J. R. Olsen et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Secukinumab for rheumatology: development and its potential place in therapy
Marije I. Koenders et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Systemic Treatment of Pediatric Psoriasis: A Review
Maddalena Napolitano et al.
DERMATOLOGY AND THERAPY (2016)
Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
Karly P. Garnock-Jones
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2015)
Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities
I. M. G. J. Bronckers et al.
PEDIATRIC DRUGS (2015)
Psoriasis in Children: A Review
Matteo Megna et al.
CURRENT PEDIATRIC REVIEWS (2015)
Epidemiology and comorbidity of psoriasis in children
M. Augustin et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
分享论文
